Translate this page into:
Synthesis and biological evaluation of 4-thiazolidinone derivatives as antitubercular and antimicrobial agents
*Corresponding author. Tel.: +91 9907653817 pushkalsamadhiya@rediffmail.com (Pushkal Samadhiya)
-
Received: ,
Accepted: ,
This article was originally published by Elsevier and was migrated to Scientific Scholar after the change of Publisher.
Available online 9 December 2010
Peer review under responsibility of King Saud University.
Abstract
New series of N-[2-{2-(substitutedphenyl)-4-oxo-5-(substitutedbenzylidene)-1,3-thiazolidine}-iminoethyl]-2-amino-5-nitrothiazole, 5(a–m) have been synthesized from 2-amino-5-nitrothiazole as a starting material by conventional as well as microwave methods. All the synthesized compounds 4(a–m) were screened for their antibacterial and antifungal activities against some selected bacteria and fungi and antitubercular activity screened against Mycobacterium tuberculosis. The structure of all the synthesized compounds were confirmed by chemical and spectral analyses such as IR, 1H NMR, 13C NMR and FAB-Mass.
Keywords
Conventional
Microwave
Synthesis
2-Amino-5-nitrothiazole
Thiazolidinone
Antimicrobial
Antitubercular
1 Introduction
4-Thiazolidine derivatives are an important class of heterocyclic compounds known for their potential pharmaceutical applications. Recently, this framework containing compounds were effective against antimicrobial (Young et al., 2004), antischistosomal activity (Taha and Soliman, 2007), antifungal (Asati et al., 2005), antiinflammatory (Jain et al., 2006), antimalarial (Kristina et al., 2009), herbicidal (Sanemitsu et al., 2006), antiviral (Eiichi et al., 2007), antidiabetic (Murugan et al., 2009), and antioxidant (Shih and Ke, 2004) activities. Thiazole derivatives are heterocyclic compounds containing nitrogen and sulfur atoms in their structure and are proved to be clinically useful agents against different kinds of disease. Thiazole derivatives have been employed in the preparation of different important drugs required for treatment of antimicrobial (Gouda et al., 2010), antibacterial (Bharti et al., 2010; Khalil et al., 2009), antifungal (Bharti et al., 2010; Joshi and Srivastava, 2001), antiinflammatory (Giri et al., 2009), and antitubercular (Shiradkar et al., 2007), some of the thiazole derivatives are used as antiprotozoal (Ricardo et al., 2003) drugs. All above biological activities of thiazole and thiazolidine derivatives aroused our attention and promoted to synthesis a new series of N-[2-{2-(substitutedphenyl)-4-oxo-5-(substitutedbenzylidene)-1,3-thiazolidine}-iminoethyl]-2-amino-5-nitrothiazole, 5(a–m) by conventional and microwave methods. The structure of compounds 1, 2, 3(a–m), 4(a–m) and 5(a–m) were confirmed by IR, 1H NMR, 13C NMR, FAB-Mass and chemical analysis. All the final synthesized compounds 5(a–m) were screened for their antimicrobial activity against some selected bacteria, fungi and antituberculosis study against M. tuberculosis. (Scheme 1)
2 Materials and methods
2.1 Experimental
Melting points were taken in open glass capillaries and are uncorrected. Progress of the reaction was monitored by silica gel-G coated TLC plates in MeOH:CHCl3 system (1:9). The spot was visualized by exposing dry plate in iodine vapours. IR spectra were recorded in KBr disc on a Schimadzu 8201 PC, FTIR spectrophotometer (νmax in cm−1) and 1H and 13C NMR spectra were measured on a Brucker DRX-300 spectrometer in CDCl3 at 300 and 75 MHz respectively using TMS as an internal standard. All chemical shifts were reported on δ scales. The FAB-Mass spectra were recorded on a Jeol SX-102 mass spectrometer. Elemental analyses were performed on a Carlo Erba-1108 analyzer. Microwave irradiation was carried out in an open glass vessel. Modified microwave oven (800 W) was used for the synthesis of compounds. A thermocouple was used to monitor the temperature inside the vessel of the microwave. The analytical data of all the compounds were highly satisfactory. For column chromatographic purification of the products, Merck silica Gel 60 (230–400 Mesh) was used. The reagent grade chemicals were purchased from the commercial sources and further purified before use.
2.2 General microwave method for synthesis of compound 1, 2, 3(a–m), 4(a–m) and 5(a–m)
A solid supported mixture of compounds (1:1 mol) was mixed thoroughly in open glass vessel and subjected to the microwave irradiation at low power setting (25%, 200 W) for 2.40–4.15 min, then allowed to cool. The products were purified over a column chromatography. The products were recrystallized from ethanol at room temperature to yield compound 1, 2, 3(a–m), 4(a–m) and 5(a–m). Results were given in Table 1.
Yield%
Reaction time
Yield%
Reaction time
Comp.
Conv.
MW
Conv. (h)
MW (min)
Comp.
Conv.
MW
Conv. (h)
MW (min)
1st stirr.
2nd reflux
1st stirr.
2nd reflux
1
62
76
6.30
–
4.00
4g
66
80
2.35
3.25
3.30
2
70
85
5.00
–
3.10
4h
64
76
2.45
3.15
3.35
3a
60
78
3.00
2.15
3.35
4i
63
80
2.15
3.30
3.15
3b
64
86
3.15
2.00
3.45
4j
61
84
2.30
3.30
3.05
3c
67
83
3.10
2.00
3.35
4k
64
83
2.15
3.35
3.20
3d
65
85
3.15
1.45
4.10
4l
63
77
2.15
3.30
3.20
3e
67
84
2.30
2.15
3.15
4m
63
80
2.10
3.45
3.20
3f
65
81
3.30
2.30
3.05
5a
66
79
2.30
3.15
3.40
3g
63
80
3.35
2.00
2.40
5b
64
76
2.00
3.05
3.20
3h
64
77
3.30
2.30
3.15
5c
62
82
2.05
2.45
3.20
3i
62
78
3.30
1.40
3.30
5d
64
84
2.15
2.45
3.25
3j
61
82
3.25
2.30
2.55
5e
62
83
2.10
3.10
3.30
3k
62
81
3.30
2.30
3.45
5f
65
82
2.15
3.00
3.15
3l
61
79
3.30
2.20
4.15
5g
64
78
2.30
3.15
3.45
3m
62
81
3.30
2.00
3.25
5h
62
79
2.00
3.30
3.30
4a
65
75
2.45
3.05
3.35
5i
64
81
2.10
3.25
3.15
4b
65
79
2.30
3.15
3.35
5j
60
80
2.15
3.15
3.15
4c
67
84
2.45
2.30
3.15
5k
66
82
2.00
3.30
3.20
4d
66
82
2.30
2.30
3.10
5l
61
75
2.20
3.25
3.45
4e
60
80
2.30
3.00
3.30
5m
62
76
2.30
3.45
3.20
4f
63
83
2.15
3.15
3.05
–
–
–
–
–
–
2.3 Conventional method for synthesis of the compound 1
A mixture of 2-amino-5-nitrothiazole and 1-bromo-2-chloroethane (1:1 mol) was dissolved in methanol at room temperature. The reaction mixture was continuously stirred on a magnetic stirrer for about 6.30 h. The product was filtered and purified over a column chromatography using chloroform: methanol (8:2 v/v). The purified product was recrystallized from ethanol at room temperature to yield compound 1.
2.3.1 Synthesis of N-(2-chloroethyl)-2-amino-5-nitrothiazole (1)
Yield: 62%, m.p. 162–166 °C; Anal. Calcd for C5H6N3O2SCl: C, 28.92, H, 2.91, N, 20.23%; found C, 28.90, H, 2.89, N, 20.13%; IR (cm−1): 740 (C—Cl), 892 (C—S), 978 (C—NO), 1382 (N—CH2), 1555 (NO2), 1569 (C⚌C), 2880, 3074 (CH), 3382 (NH); 1H NMR (δ): 4.20 (t, 2H, J = 7.60 Hz, CH 2—Cl), 4.80 (t, 2H, J = 7.60 Hz, N—CH2), 7.80 (br s, 1H, NH), 7.23 (s, 1H, C4H of thiazole); 13C NMR (δ): 44.4 (CH2—Cl), 56.5 (N—CH2), 111.2 (C5 of thiazole), 137.5 (C4 of thiazole), 167.5 (C2 of thiazole), Mass (FAB): 208M+, 172, 158, 144, 129, 117, 114, 99, 83.
2.4 Conventional method for synthesis of the compound 2
A mixture of compound 1 and hydrazine hydrate (1:1 mol) was dissolved in methanol at room temperature. The reaction mixture was continuously stirred on a magnetic stirrer for about 5.00 h. The product was filtered and purified over a column chromatography using chloroform: methanol (7:3 v/v). The purified product was recrystallized from ethanol at room temperature to yield compound 2.
2.4.1 Synthesis of N-{2-(hydrazino)-ethyl}-2-amino-5-nitrothiazole (2)
Yield: 70%, m.p. 142–146 °C; Anal. Calcd for C5H9N5O2S: C, 29.55, H, 4.46, N, 34.46%; found C, 29.50, H, 4.42, N, 34.41%; IR: 870 (C—N), 878 (C—S), 1338 (N—CH2), 1528 (NO2), 3376 (NH), 3370 (NH), 3480 (NH2); 1H NMR (δ): 4.27 (t, 2H, J = 7.60 Hz, CH2—NH), 4.92 (t, 2H, J = 7.60 Hz, N—CH2), 5.55 (s, 2H, NH2), 7.70 (s, 1H, NH), 7.96 (br s, 1H, NH), 7.25 (s, 1H, C4H of thiazole); 13C NMR (δ): 47.5 (CH2—NH), 57.4 (N—CH2), 107.8 (C5 of thiazole), 138.8 (C4 of thiazole), 169.9 (C2 of thiazole); Mass (FAB): 203M+, 187, 172.
2.5 General conventional method for synthesis of compound 3(a–m)
A mixture of compound 2 and substituted benzaldehydes (1:1 mol) was dissolved in methanol at room temperature and allowed to react. The reaction mixture was first continuously stirred on a magnetic stirrer for about 2.30–3.35 h then kept on a steam bath for about 1.45–2.30 h. The products were cooled and filtered. The products were purified over a column chromatography using chloroform: ethanol (8:2 v/v) and recrystallized from ethanol at room temperature to yield compound 3(a–m).
2.5.1 Synthesis of N-{2-(benzylidenimino)-ethyl}-2-amino-5-nitrothiazole (3a)
Yield: 60%, m.p. 151–154 °C; Anal. Calcd for C12H13N5O2S: C, 49.47, H, 4.49, N, 24.03%; found C, 49.40, H, 4.42, N, 24.00%; IR: 1553 (N⚌CH), 3378 (NH); 1H NMR (δ): 4.25 (t, 2H, J = 7.45 Hz, CH2—NH), 4.78 (t, 2H, J = 7.45 Hz, N—CH2), 7.60 (s, 1H, NH), 7.76 (br s, 1H, NH), 7.89 (s, 1H, N⚌CH), 7.21 (s, 1H, C4H of thiazole), 6.38–7.36 (m, 5H, Ar—H); 13C NMR (δ): 46.5 (CH2—N), 54.9 (N—CH2), 112.4 (C5 of thiazole),140.9 (C4 of thiazole), 141.6 (N⚌CH), 167.9 (C2 of thiazole), 124.7, 127.8, 127.8, 129.6, 130.2, 137.9 (6C, Ar); Mass (FAB): 291M+, 214, 187.
2.5.2 Synthesis of N-{2-(4-chlorobenzylidenimino)-ethyl}-2-amino-5-nitrothiazole (3b)
Yield: 64%, m.p. 162–166 °C; Anal. Calcd for C12H12N5O2SCl: C, 44.24, H, 3.71, N, 21.49%; found C, 44.22, H, 3.69, N, 21.45%; IR: 740 (C—Cl), 1562 (N⚌CH), 3372 (NH); 1H NMR (δ): 4.55 (t, 2H, J = 7.40 Hz, CH2—NH), 4.90 (t, 2H, J = 7.40 Hz, N—CH2), 7.36 (s, 1H, C4H of thiazole), 7.55 (s, 1H, NH), 7.82 (br s, 1H, NH), 8.02 (s, 1H, N⚌CH), 6.45–7.65 (m, 4H, Ar—H); 13C NMR (δ): 49.6 (CH2—NH), 58.5 (N—CH2), 116.8 (C5 of thiazole), 143.5 (C4 of thiazole), 152.7 (N⚌CH), 174.5 (C2 of thiazole), 126.8, 128.6, 128.9, 130.8, 135.7, 138.6 (6C, Ar); Mass (FAB): 326M+, 290, 214, 201, 187, 180.
2.5.3 Synthesis of N-{2-(3-chlorobenzylidenimino)-ethyl}-2-amino-5-nitrothiazole (3c)
Yield: 67%, m.p. 167–170 °C; Anal. Calcd for C12H12N5O2SCl: C, 44.24, H, 3.71, N, 21.49%; found C, 44.20, H, 3.70, N, 21.40%; IR: 747 (C—Cl), 1560 (N⚌CH), 3384 (NH); 1H NMR (δ): 4.58 (t, 2H, J = 7.45 Hz, CH2—NH), 4.95 (t, 2H, J = 7.45 Hz, N—CH2), 7.40 (s, 1H, C4H of thiazole), 7.60 (s, 1H, NH), 7.76 (br s, 1H, NH), 8.09 (s, 1H, N⚌CH), 6.40–7.69 (m, 4H, Ar—H); 13C NMR (δ): 45.5 (CH2—NH), 48.3 (N—CH2), 114.3 (C5 of thiazole), 143.4 (C4 of thiazole), 153.8 (N⚌CH), 173.8 (C2 of thiazole), 126.8, 128.7, 129.8, 130.5, 135.5, 139.2A (6C, Ar); Mass (FAB): 326M+.
2.5.4 Synthesis of N-{2-(2-chlorobenzylidenimino)-ethyl}-2-amino-5-nitrothiazole (3d)
Yield: 65%, m.p. 162–165 °C; Anal. Calcd for C12H12N5O2SCl: C, 44.24, H, 3.71, N, 21.49%; found C, 44.18, H, 3.68, N, 21.42%; IR: 741 (C—Cl), 1560 (N⚌CH), 3372 (NH); 1H NMR (δ): 4.56 (t, 2H, J = 7.50 Hz, CH2—NH), 4.98 (t, 2H, J = 7.50 Hz, N— CH 2), 7.36 (s, 1H, C4H of thiazole), 7.53 (s, 1H, NH), 7.80 (br s, 1H, NH), 8.12 (s, 1H, N⚌CH), 6.35–7.71 (m, 4H, Ar—H); 13C NMR (δ): 48.4 ( CH 2—NH), 58.6 (N— CH 2), 112.4 (C5 of thiazole), 142.7 (C4 of thiazole), 155.9 (N⚌CH), 173.8 (C2 of thiazole), 127.6, 128.9, 130.8, 131.7, 135.8, 139.8 (6C, Ar); Mass (FAB): 326M+.
2.5.5 Synthesis of N-{2-(4-bromobenzylidenimino)-ethyl}-2-amino-5-nitrothiazole (3e)
Yield: 67%, m.p. 172–175 °C; Anal. Calcd for C12H12N5O2SBr: C, 38.93, H, 3.26, N, 18.91%; found C, 38.90, H, 3.22, N, 18.89%; IR: 632 (C—Br), 1609 (N⚌CH), 3372 (NH); 1H NMR (δ): 4.50 (t, 2H, J = 7.50 Hz, CH 2—NH), 5.10 (t, 2H, J = 7.50 Hz, N— CH 2), 7.27 (s, 1H, C4H of thiazole), 7.64 (s, 1H, NH), 7.90 (br s, 1H, NH), 8.02 (s, 1H, N⚌CH), 6.53–7.90 (m, 4H, Ar—H); 13C NMR (δ): 48.7 ( CH 2—NH), 56.2 (N— CH 2), 112.7 (C5 of thiazole), 142.8 (C4 of thiazole), 152.5 (N⚌CH), 167.5 (C2 of thiazole), 125.9, 127.2, 128.6, 129.4, 135.7, 137.9 (6C, Ar); Mass (FAB): 370M+, 290, 214.
2.5.6 Synthesis of N-{2-(3-bromobenzylidenimino)-ethyl}-2-amino-5-nitrothiazole (3f)
Yield: 65%, m.p. 177–180 °C; Anal. Calcd for C12H12N5O2SBr: C, 38.93, H, 3.26, N, 18.91%; found C, 38.90, H, 3.20, N, 18.89%; IR: 640 (C—Br), 1570 (N⚌CH), 3370 (NH); 1H NMR (δ): 4.54 (t, 2H, J = 7.45 Hz, CH 2 –NH), 4.95 (t, 2H, J = 7.45 Hz, N— CH 2), 7.28 (s, 1H, C4H of thiazole), 7.61 (s, 1H, NH), 7.88 (br s, 1H, NH), 8.06 (s, 1H, N⚌CH), 6.54–7.92 (m, 4H, Ar—H); 13C NMR (δ): 48.4 ( CH 2—N), 57.5 (N— CH 2), 113.8 (C5 of thiazole), 145.2 (C4 of thiazole),155.4 (N⚌CH), 167.4 (C2 of thiazole), 126.3, 127.8, 128.7, 130.8, 135.9, 138.5 (6C, Ar); Mass (FAB): 370M+.
2.5.7 Synthesis of N-{2-(2-bromobenzylidenimino)-ethyl}-2-amino-5-nitrothiazole (3g)
Yield: 63%, m.p. 173–176 °C; Anal. Calcd for C12H12N5O2SBr: C, 38.93, H, 3.26, N, 18.91%; found C, 38.88, H, 3.20, N, 18.83%; IR: 647 (C—Br), 1570 (N⚌CH), 3370 (NH); 1H NMR (δ): 4.58 (t, 2H, J = 7.40 Hz, CH 2—NH), 5.10 (t, 2H, J = 7.40 Hz, N— CH 2), 7.28 (s, 1H, C4H of thiazole), 7.54 (s, 1H, NH), 7.85 (br s, 1H, NH), 8.11 (s, 1H, N⚌CH), 6.62–7.92 (m, 4H, Ar—H); 13C NMR (δ): 49.6 ( CH 2—NH), 58.4 (N— CH 2), 113.3 (C5 of thiazole), 142.5 (C4 of thiazole), 156.2 (N⚌CH), 169.6 (C2 of thiazole), 126.6, 127.8, 129.8, 130.6, 136.7, 138.8 (6C, Ar); Mass (FAB): 370M+.
2.5.8 Synthesis of N-{2-(4-nitrobenzylidenimino)-ethyl}-2-amino-5-nitrothiazole (3h)
Yield: 64%, m.p. 169–172 °C; Anal. Calcd for C12H12N6O4S: C, 42.85, H, 3.59, N, 24.98%; found C, 42.80, H, 3.52, N, 24.93%; IR: 848 (C—N), 1549 (N⚌O), 1576 (N⚌CH), 3370 (NH); 1H NMR (δ): 4.60 (t, 2H, J = 7.35 Hz, CH 2—NH), 5.05 (t, 2H, J = 7.35 Hz, N— CH 2), 7.36 (s, 1H, C4H of thiazole), 7.45 (s, 1H, NH), 7.99 (br s, 1H, NH), 8.17 (s, 1H, N⚌CH), 7.04–8.05 (m, 4H, Ar—H); 13C NMR (δ): 49.7 ( CH 2—N), 59.3 (N— CH 2), 113.9 (C5 of thiazole), 143.7 (C4 of thiazole), 154.8 (N⚌CH), 170.8 (C2 of thiazole), 127.6, 128.8, 129.7, 131.9, 136.7, 143.9 (6C, Ar); Mass (FAB): 336M+, 306, 290, 214.
2.5.9 Synthesis of N-{2-(3-nitrobenzylidenimino)-ethyl}-2-amino-5-nitrothiazole (3i)
Yield: 62%, m.p. 166–169 °C; Anal. Calcd for C12H12N6O4S: C, 42.85, H, 3.59, N, 24.98%; found C, 42.82, H, 3.55, N, 24.94%; IR: 842 (C—N), 1536 (N⚌O), 1572 (N⚌CH), 3370 (NH); 1H NMR (δ): 4.50 (t, 2H, J = 7.50 Hz, CH 2—NH), 4.94 (t, 2H, J = 7.50 Hz, N— CH 2), 7.50 (s, 1H, NH), 7.90 (br s, 1H, NH), 7.45 (s, 1H, C4H of thiazole), 8.13 (s, 1H, N⚌CH), 7.10–8.20 (m, 4H, Ar—H); 13C NMR (δ): 47.9 ( CH 2—NH), 57.6 (N— CH 2), 114.6 (C5 of thiazole), 143.8 (C4 of thiazole), 154.7 (N⚌CH), 170.8 (C2 of thiazole), 125.7, 129.8, 130.9, 131.6, 137.8, 144.6 (6C, Ar); Mass (FAB): 336M+.
2.5.10 Synthesis of N-{2-(2-nitrobenzylidenimino)-ethyl}-2-amino-5-nitrothiazole (3j)
Yield: 61%, m.p. 163–165 °C; Anal. Calcd for C12H12N6O4S: C, 42.85, H, 3.59, N, 24.98%; found C, 42.83, H, 3.55, N, 24.90%; IR: 845 (C—N), 1542 (N⚌O), 1570 (N⚌CH), 3344 (NH); 1H NMR (δ): 4.42 (t, 2H, J = 7.50 Hz, CH 2—NH), 4.69 (t, 2H, J = 7.50 Hz, N— CH 2), 7.45 (s, 1H, NH), 7.95 (br s, 1H, NH), 7.34 (s, 1H, C4H of thiazole), 8.09 (s, 1H, N⚌CH), 6.95–8.10 (m, 4H, Ar—H); 13C NMR (δ): 49.4 ( CH 2—NH), 59.8 (N— CH 2), 116.9 (C5 of thiazole), 144.8 (C4 of thiazole), 156.6 (N⚌CH), 171.8 (C2 of thiazole), 126.4, 129.7, 131.3, 131.6, 138.5, 145.8 (6C, Ar); Mass (FAB): 336M+.
2.5.11 Synthesis of N-{2-(4-methoxybenzylidenimino)-ethyl}-2-amino-5-nitrothiazole (3k)
Yield: 62%, m.p. 139–142 °C; Anal. Calcd for C13H15N5O3S: C, 48.58, H, 4.70, N, 21.79%; found C, 48.555, H, 4.62, N, 21.72%; IR: 1569 (N⚌CH), 2948 (OCH3), 3368 (NH); 1H NMR (δ): 4.49 (t, 2H, J = 7.45 Hz, CH 2—NH), 4.66 (s, 3H, OCH3), 4.98 (t, 2H, J = 7.45 Hz, N— CH 2), 7.32 (s, 1H, C4H of thiazole), 7.46 (s, 1H, NH), 7.73 (br s, 1H, NH), 7.91 (s, 1H, N⚌CH), 6.66–7.59 (m, 4H, Ar—H); 13C NMR (δ): 48.7 ( CH 2—NH), 52.5 (OCH3), 57.7 (N— CH 2), 154.8 (N⚌CH), 171.4 (C2 of thiazole), 114.8 (C5 of thiazole), 138.7 (C4 of thiazole), 113.7, 117.6, 123.8, 127.5, 136.9, 161.8 (6C, Ar); Mass (FAB): 321M+, 306, 278, 214.
2.5.12 Synthesis of N-{2-(4-methylbenzylidenimino)-ethyl}-2-amino-5-nitrothiazole (3l)
Yield: 61%, m.p. 135–138 °C; Anal. Calcd for C13H15N5O2S: C, 51.13, H, 4.95, N, 22.93%; found C, 51.10, H, 4.90, N, 22.91%; IR: 1549 (N⚌CH), 2927 (CH3), 3360 (NH); 1H NMR (δ): 2.61 (s, 3H, CH3), 4.38 (t, 2H, J = 7.40 Hz, CH 2—NH), 4.92 (t, 2H, J = 7.40 Hz, N— CH 2), 7.16 (s, 1H, C4H of thiazole), 7.32 (s, 1H, NH), 7.60 (br s, 1H, NH), 7.86 (s, 1H, N⚌CH), 6.65–7.45 (m, 4H, Ar—H); 13C NMR (δ): 26.6 (CH3), 47.4 ( CH 2—NH), 56.5 (N— CH 2), 111.4 (C5 of thiazole), 137.9 (C4 of thiazole), 152.8 (N⚌CH), 171.5 (C2 of thiazole), 124.4, 127.7, 128.6, 129.6, 134.5, 137.6 (6C, Ar); Mass (FAB): 305M+, 279, 214.
2.5.13 Synthesis of N-{2-(4-hydroxybenzylidenimino)-ethyl}-2-amino-5-nitrothiazole (3m)
Yield: 62%, m.p. 131–134 °C; Anal. Calcd for C12H13N5O3S: C, 46.89, H, 4.26, N, 22.78%; found C, 46.85, H, 4.22, N, 22.73%; IR: 1559 (N⚌CH), 3388 (NH), 3477 (OH); 1H NMR (δ): 4.53 (t, 2H, J = 7.35 Hz, CH 2—NH), 4.29 (s, 1H, OH), 5.09 (t, 2H, J = 7.35 Hz, N— CH 2), 7.30 (s, 1H, C4H of thiazole), 7.57 (s, 1H, NH), 7.78 (br s, 1H, NH), 7.90 (s, 1H, N⚌CH), 6.50–7.49 (m, 4H, Ar—H); 13C NMR (δ): 49.5 ( CH 2—NH), 59.7 (N— CH 2), 112.8 (C5 of thiazole), 140.6 (C4 of thiazole), 153.4 (N⚌CH), 170.6 (C2 of thiazole), 111.7, 116.4, 123.8, 128.9, 137.5, 154.8 (6C, Ar); Mass (FAB)1: 307M+, 290, 216, 181.
2.6 General conventional methods for synthesis of compound 4(a–m)
A mixture of compound 3(a–m) and thioglycolic acid (1:1 mol) dissolved in methanol was allow to react in the presence of a catalytic amount of ZnCl2. The reaction mixture was first continuously stirred on a magnetic stirrer for about 2.10–2.30 h then kept on steam bath for about 1.45–4.15 h at 80–90 °C. The products were cooled and filtered at room temperature. The filtered products were purified over column chromatography using chloroform: ethanol (7:3 v/v) and recrystallized from ethanol at room temperature to yield compound 4(a–m).
2.6.1 Synthesis of N-2-[-{-(2-phenyl-4-oxo-1-3-thiazolidine}-imino]-ethyl-2-amino-5-nitrothiazole (4a)
Yield: 65%, m.p. 161–164 °C; Anal. Calcd for C14H15N5O3S2: C, 46.01, H, 4.13, N, 19.16%; found C, 45.96, H, 4.10, N, 19.10%; IR: 678 (C—S—C), 748 (C—Cl), 1329 (C—N), 1738 (CO cyclic), 2912 (S—CH2); 1H NMR 3.10 (s, 2H, S—CH2), 4.96 (d, 1H, N—CH), 7.26 (s, 1H, C4H of thiazole), 6.45–7.45 (m, 4H, Ar—H); 13C NMR (δ): 35.5 (CH2—S), 56.2 (N—CH), 111.8 (C5 of thiazole), 137.8 (C4 of thiazole), 168.7 (CO cyclic), 170.6 (C2 of thiazole), 124.7, 126.7, 127.5, 128.8, 131.9, 137.7 (6C, Ar); Mass (FAB): 365M+, 337, 260, 187, 178. 150.
2.6.2 Synthesis of N-2-[-{2-(4-chlorophenyl)-4-oxo-1-3-thiazolidine-imino}-ethyl-2-amino-5-nitrothiazole (4b)
Yield: 65%, m.p. 178–181 °C; Anal. Calcd for C14H14N5O3S2Cl: C, 42.05, H, 3.52, N, 17.51%; found C, 42.00, H, 3.49, N, 17.47%; IR: 689 (C—S—C), 738 (C—Cl), 1345 (C—N), 1749 (CO cyclic), 2946 (S—CH2); 1H NMR: 3.30 (s, 2H, S—CH2), 4.98 (d, 1H, N—CH), 7.31 (s, 1H, C4H of thiazole), 6.64–7.78 (m, 4H, Ar—H—H); 13C NMR (δ): 34.4 (CH2—S), 58.2 (N—CH), 116.7 (C5 of thiazole), 140.4 (C4 of thiazole), 177.9 (CO cyclic), 171.8 (C2 of thiazole), 124.7, 126.8, 127.7, 128.5, 129.8, 138.5 (6C, Ar); Mass (FAB): 400M+, 372, 365, 185, 178.
2.6.3 Synthesis of N-2-[-{2-(3-chlorophenyl)-4-oxo-1-3-thiazolidine-imino}-ethyl-2-amino-5-nitrothiazole (4c)
Yield: 67%, m.p. 176–178 °C; Anal. Calcd for C14H14N5O3S2Cl: C, 42.05, H, 3.52, N, 17.51%; found C, 42.01, H, 3.46, N, 17.45%; IR: 672 (C—S—C), 749 (C—Cl), 1338 (C—N), 1744 (CO cyclic), 2930 (S—CH2); 1H NMR: 3.40 (s, 2H, S—CH2), 4.90 (d, 1H, N—CH), 7.40 (s, 1H, C4H of thiazole), 6.72–7.74 (m, 4H, Ar—H); 13C NMR (δ): 39.5 (CH2—S), 53.4 (N—CH), 109.7 (C5 of thiazole), 139.5 (C4 of thiazole), 176.9 (CO cyclic), 171.6 (C2 of thiazole), 125.9, 127.8, 128.6, 128.6, 130.5, 136.9 (6C, Ar); Mass (FAB): 400M+.
2.6.4 Synthesis of N-2-[-{2-(2-chlorophenyl)-4-oxo-1-3-thiazolidine}-imino]-ethyl-2-amino-5-nitrothiazole (4d)
Yield: 66%, m.p. 174–177 °C; Anal. Calcd for C14H14N5O3S2Cl: C, 42.05, H, 3.52, N, 17.51%; found C, 42.03, H, 3.49, N, 17.45%; IR: 678 (C—S—C), 758 (C—Cl), 1339 (C—N), 1748 (CO cyclic), 2938 (S—CH2); 1H NMR: 3.40 (s, 2H, S—CH2), 4.93 (d, 1H, N—CH), 7.36 (s, 1H, C4H of thiazole), 6.67–7.76 (m, 4H, Ar—H); 13C NMR (δ): 39.6 (CH2—S), 60.7 (N—CH), 112.5 (C5 of thiazole), 138.9 (C4 of thiazole), 174.9 (CO cyclic), 172.5 (C2 of thiazole), 125.7, 127.6, 127.9, 128.4, 129.6, 137.9 (6C, Ar); Mass (FAB): 400M+.
2.6.5 Synthesis of N-2-[-{2-(4-bromophenyl)-4-oxo-1-3-thiazolidine}-imino]-ethyl-2-amino-5-nitrothiazole (4e)
Yield: 60%, m.p. 187–190 °C; Anal. Calcd for C14H14N5O3S2Br: C, 37.84, H, 3.17, N, 15.76%; found C, 37.80, H, 3.12, N, 15.76%; IR: 688 (C—S—C), 758 (C—Br), 1345 (C—N), 1748 (CO cyclic), 2946 (S—CH2); 1H NMR: 3.42 (s, 2H, S—CH2), 4.89 (d, 1H, N—CH), 7.39 (s, 1H, C4H of thiazole), 6.46–7.91 (m, 4H, Ar—H); 13C NMR (δ): 40.5 (CH2—S), 61.6 (N—CH), 112.8 (C5 of thiazole), 139.8 (C4 of thiazole), 173.9 (CO cyclic), 172.2 (C2 of thiazole), 125.8, 126.9, 127.6, 128.8, 129.8, 137.5 (6C, Ar); Mass (FAB): 444M+, 416, 364, 257, 229, 187, 177, 149.
2.6.6 Synthesis of N-2-[-{2-(3-bromophenyl)-4-oxo-1-3-thiazolidine}-imino]-ethyl-2-amino-5-nitrothiazole (4f)
Yield: 63%, m.p. 185–187 °C; Anal. Calcd for C14H14N5O3S2Br: C, 37.84, H, 3.17, N, 15.76%; found C, 37.81, H, 3.10, N, 15.74%; IR: 670 (C—S—C), 748 (C—Br), 1339 (C—N), 1738 (CO cyclic), 2936 (S—CH2); 1H NMR: 3.44 (s, 2H, S—CH2), 4.85 (d, 1H, N—CH), 7.30 (s, 1H, C4H of thiazole), 6.61–7.98 (m, 4H, Ar—H); 13C NMR (δ): 38.4 (CH2—S), 54.3 (N—CH), 110.2 (C5 of thiazole), 137.6 (C4 of thiazole), 175.4 (CO cyclic), 171.2 (C2 of thiazole), 126.7, 127.8, 128.8, 129.6, 130.4, 137.3 (6C, Ar); Mass (FAB): 444.
2.6.7 Synthesis of N-2-[-{2-(2-bromophenyl)-4-oxo-1-3-thiazolidine}-imino]-ethyl-2-amino-5-nitrothiazole (4g)
Yield: 66%, m.p. 180–183 °C; Anal. Calcd for C14H14N5O3S2Br: C, 37.84, H, 3.17, N, 15.76%; found C, 37.78, H, 3.11, N, 15.69%; IR: 675 (C—S—C), 742 (C—Br), 1332 (C—N), 1738 (CO cyclic), 2920 (S—CH2); 1H NMR: 3.46 (s, 2H, S—CH2), 4.88 (d, 1H, N—CH), 7.32 (s, 1H, C4H of thiazole), 6.85–7.96 (m, 4H, Ar—H); 13C NMR (δ): 34.6 (CH2—S), 51.6 (N—CH), 113.4 (C5 of thiazole), 138.8 (C4 of thiazole), 171.5 (CO cyclic), 167.6 (C2 of thiazole), 126.5, 127.6, 128.8, 129.4, 130.8, 137.3 (6C, Ar); Mass (FAB): 444M+.
2.6.8 Synthesis of N-2-[-{2-(4-nitrophenyl)-4-oxo-1-3-thiazolidine}-imino]-ethyl-2-amino-5-nitrothiazole (4h)
Yield: 64%, m.p. 187–189 °C; Anal. Calcd for C14H14N6O5S2: C, 40.96, H, 3.43, N, 20.47%; found C, 40.93, H, 3.40, N, 20.40%; IR: 687 (C—S—C), 1020 (NO), 1329 (C—N), 1548 (NO2), 1748 (CO cyclic), 2936 (S—CH2); 1H NMR: 3.40 (s, 2H, S—CH2), 4.85 (d, 1H, N—CH), 7.32 (s, 1H, C4H of thiazole), 6.98–7.97 (m, 4H, Ar—H); 13C NMR (δ): 38.7 (CH2—S), 57.4 (N—CH), 113.4 (C5 of thiazole), 138.4 (C4 of thiazole), 174.6 (CO cyclic), 169.2 (C2 of thiazole), 126.7, 127.7, 128.6, 129.8, 129.9, 136.6 (6C, Ar); Mass (FAB): 410M+, 380, 364, 336, 280, 223, 195, 149, 117.
2.6.9 Synthesis of N-2-[-{2-(3-nitrophenyl)-4-oxo-1-3-thiazolidine}-imino]-ethyl-2-amino-5-nitrothiazole (4i)
Yield: 63%, m.p. 182–186 °C; Anal. Calcd for C14H14N6O5S2: C, 40.96, H, 3.43, N, 20.47%; found C, 40.90, H, 3.39, N, 20.41%; IR: 674 (C—S—C), 745 (C—Cl), 1020 (NO), 1326 (C—N), 1547 (NO2), 1746 (CO cyclic), 2986 (S—CH2); 1H NMR: 3.37 (s, 2H, S—CH2), 4.94 (d, 1H, N—CH), 7.39 (s, 1H, C4H of thiazole), 6.90–8.13 (m, 4H, Ar—H); 13C NMR (δ): 42.8 (CH2—S), 61.7 (N—CH), 111.7 (C5 of thiazole), 139.6 (C4 of thiazole), 173.9 (CO cyclic), 172.1 (C2 of thiazole), 126.8, 127.8, 128.8, 129.9, 131.9, 135.7 (6C, Ar); Mass (FAB): 410M+.
2.6.10 Synthesis of N-2-[-{2-(2-nitrophenyl)-4-oxo-1-3-thiazolidine}-imino]-ethyl-2-amino-5-nitrothiazole (4j)
Yield: 61%, m.p. 179–181 °C; Anal. Calcd for C14H14N6O5S2: C, 40.96, H, 3.43, N, 20.47%; found C, 40.92, H, 3.38, N, 20.42%; IR: 670 (C—S—C), 743 (C—Cl), 1012 (NO), 1325 (C—N), 1539 (NO2), 1736 (CO cyclic), 2988 (S—CH2); 1H NMR: 3.31 (s, 2H, S—CH2), 4.97 (d, 1H, N—CH), 7.39 (s, 1H, C4H of thiazole), 7.02–8.11 (m, 4H, Ar—H); 13C NMR (δ): 45.8 (CH2—S), 60.6 (N—CH), 114.4 (C5 of thiazole), 141.5 (C4 of thiazole), 172.2 (C2 of thiazole), 174.6 (CO cyclic), 126.3, 127.8, 128.7, 129.6, 130.5, 138.9 (6C, Ar); Mass (FAB): 410M+.
2.6.11 Synthesis of N-2-[-{2-(4-methoxyphenyl)-4-oxo-1-3-thiazolidine}-imino]-ethyl-2-amino-5-nitrothiazole (4k)
Yield: 64%, m.p. 165–167 °C; Anal. Calcd for C15H17N5O4S2: C, 45.55, H, 4.33, N, 17.70%; found C, 45.52, H, 4.30, N, 17.65%; IR: 670 (C—S—C), 1334 (C—N), 1742 (CO cyclic), 2935 (S—CH2), 3024 (OCH3); 1H NMR: 3.25 (s, 2H, S—CH2), 3.58 (s, 3H, OCH3), 4.89 (d, 1H, N—CH), 7.29 (s, 1H, C4H of thiazole), 6.66–7.69 (m, 4H, Ar—H); 13C NMR (δ): 41.6 (CH2—S), 57.9 (N—CH), 53.8 (OCH3), 111.8 (C5 of thiazole), 138.8 (C4 of thiazole), 171.8 (CO cyclic), 172.6 (C2 of thiazole), 125.6, 127.8, 128.4, 129.6, 133.4, 139.4 (6C, Ar); Mass (FAB): 395M+, 380, 367, 364, 352, 336, 208, 193, 187, 180, 177.
2.6.12 Synthesis of N-2-[-{2-(4-methylphenyl)-4-oxo-1-3-thiazolidine}-imino]-ethyl-2-amino-5-nitrothiazole (4l)
Yield: 63%, m.p. 163–165 °C; Anal. Calcd for C15H17N5O3S2: C, 47.47, H, 4.51, N, 18.45%; found C, 47.43, H, 4.47, N, 18.40%; IR: 670 (C—S—C), 743 (C—Cl), 1327 (C—N), 1740 (CO cyclic), 2933 (S—CH2), 2932 (CH3); 1H NMR: 2.77 (s, 3H, CH3), 3.29 (s, 2H, S—CH2), 4.74 (d, 1H, N—CH), 7.32 (s, 1H, C4H of thiazole), 6.49–7.74 (m, 4H, Ar—H); 13C NMR (δ): 27.4 (CH3), 46.6 (CH2—S), 60.6 (N—CH), 109.5 (C5 of thiazole), 137.8 (C4 of thiazole), 172.4 (CO cyclic), 167.2 (C2 of thiazole), 126.9, 127.7, 128.3, 132.7, 136.9 (6C, Ar); Mass (FAB): 379M+, 353, 325, 261.
2.6.13 Synthesis of N-2-[-{2-(4-hydroxyphenyl)-4-oxo-1-3-thiazolidine}-imino]-ethyl-2-amino-5-nitrothiazole (4m)
Yield: 63%, m.p. 160–162 °C; Anal. Calcd for C14H15N5O4S2: C, 44.08, H, 3.96, N, 18.36%; found C, 44.02, H, 3.93, N, 18.32%; IR: 679 (C—S—C), 1336 (C—N), 1743 (CO cyclic), 2938 (S—CH2), 3449 (OH); 1H NMR: 3.40 (s, 2H, S—CH2), 4.46 (s, 1H, OH), 4.81 (d, 1H, N—CH), 7.31 (s, 1H, C4H of thiazole), 6.54–7.45 (m, 4H, Ar—H); 13C NMR (δ): 50.7 (CH2—S), 61.5 (N—CH), 111.7 (C5 of thiazole), 138.8 (C4 of thiazole), 174.6 (CO cyclic), 168.6 (C2 of thiazole), 126.74, 127.6, 128.6, 129.8, 132.5, 137.5 (6C, Ar); Mass (FAB): 381M+, 364, 325, 194, 166.
2.7 General conventional method for synthesis of compound 5(a–m)
A mixture of compound 4(a–m) and substituted benzaldehydes (1:1 mol) was dissolved in methanol in the presence of alkali metal alkoxide (C2H5ONa) and allow to react. The reaction mixture was first continuously stirred on a magnetic stirrer for about 2.00–2.30 h then kept on steam bath for about 2.45–3.45 h at 80–90 °C. The products were cooled and filtered at room temperature. The filtered products were purified over column chromatography using chloroform: methanol (7:3 v/v) and recrystallized from acetone at room temperature to yield final products compound 5(a–m).
2.7.1 Synthesis of N-2-[-{2-phenyl-4-oxo-5-benylidene-1-3-thiazolidine}-imino]-ethyl-2-amino-5-nitrothiazole (5a)
Yield: 66%, m.p. 161–163 °C; Anal. Calcd for C21H19N5O3S2: C, 55.61, H, 4.22, N, 15.44%; found C, 55.56, H, 4.20, N, 15.41%; IR: 1508 (C⚌CH), 2978 (C⚌CH); 1H NMR: 6.25 (s, 1H, C⚌ CH ), 7.22 (s, 1H, C4H of thiazole), 6.42–7.42 (m, 10H, Ar—H); 13C NMR (δ): 110.6 (C5 of thiazole), 139.6 (C4 of thiazole), 143.6 (C⚌ CH ), 146.8 (C⚌CH), 170 (C2 of thiazole), 170.7 (CO cyclic), 124.5, 125.6, 125.9, 126.8, 126.9, 127.8, 127.9, 128.9, 128.9, 129.7, 137.8, 138.9 (12C, Ar); Mass (FAB): 454M+, 426, 377, 349.
2.7.2 Synthesis of N-2-[-{2-(4-chlorophenyl)-4-oxo-5-(4-chlorobenzylidene)-1-3-thiazolidine}-imino]-ethyl-2-amino-5-nitrothiazole (5b)
Yield: 64%, m.p. 166–169 °C; Anal. Calcd for C21H17N5O3S2Cl2: C, 48.27, H, 3.27, N, 13.40%; found C, 48.20, H, 3.22, N, 13.36%; IR: 1520 (C⚌CH), 2946 (C⚌CH); 1H NMR: 6.47 (s, 1H, C⚌ CH ), 7.32 (s, 1H, C4H of thiazole), 6.47–7.69 (m, 8H, Ar—H); 13C NMR (δ): 112.7 (C5 of thiazole), 141.5 (C4 of thiazole), 144.8 (C⚌ CH ), 147.8 (C⚌CH), 172.1 (C2 of thiazole), 175.7 (CO cyclic), 126.7, 127.6, 128.5, 128.9, 129.4, 129.8, 130.7, 131.6, 132.8, 133.8, 134.7, 138.9 (12C, Ar); Mass (FAB): 522M+, 494, 487, 411, 383, 307.
2.7.3 Synthesis of N-2-[-{-5-(3-chlorobenzylidene)-2-(3-chlorophenyl)-4-oxo-1-3-thiazolidine}-imino]-ethyl-2-amino-5-nitrothiazole (5c)
Yield: 62%, m.p. 164–166 °C; Anal. Calcd for C21H17N5O3S2Cl2: C, 48.27, H, 3.27, N, 13.40%; found C, 48.23, H, 3.21, N, 13.35%; IR: 1526 (C⚌CH), 2952 (C⚌CH); 1H NMR: 6.45 (s, 1H, C⚌ CH ), 7.42 (s, 1H, C4H of thiazole), 6.58–7.60 (m, 8H, Ar—H); 13C NMR (δ): 111.6 (C5 of thiazole), 140.8 (C4 of thiazole), 143.5 (C⚌ CH ), 146.8 (C⚌CH), 171.5 (C2 of thiazole), 173.3 (CO cyclic), 126.2, 126.7, 127.4, 127.8, 128.3, 128.7, 129.5, 131.6, 132.8, 133.4, 134.2, 137.8 (12C, Ar); Mass (FAB): 522M+.
2.7.4 Synthesis of N-2-[-{2-(2-chlorophenyl)-4-oxo-5-(2-chlorobenzylidene)-1-3-thiazolidine}-imino]-ethyl-2-amino-5-nitrothiazole (5d)
Yield: 64%, m.p. 162–164 °C; Anal. Calcd for C21H17N5O3S2Cl2: C, 48.27, H, 3.27, N, 13.40%; found C, 48.25, H, 3.22, N, 13.33%; IR: 1525 (C⚌CH), 2938 (C⚌CH); 1H NMR: 6.48 (s, 1H, C⚌ CH ), 7.46 (s, 1H, C4H of thiazole), 6.50–7.65 (m, 8H, Ar—H); 13C NMR (δ): 110.8 (C5 of thiazole), 139.9 (C4 of thiazole), 144.6 (C⚌ CH ), 146.9 (C⚌CH), 171.8 (C2 of thiazole), 173.4 (CO cyclic), 126.9, 126.9, 127.4, 127.8, 128.5, 129.8, 130.6, 132.8, 133.7, 134.4, 135.7, 138.8 (12C, Ar); Mass (FAB): 522M+.
2.7.5 Synthesis of N-2-[-{2-(4-bromophenyl)-4-oxo-5-(4-bromobenzylidene)-1-3-thiazolidine}-imino]-ethyl-2-amino-5-nitrothiazole (5e)
Yield: 62%, m.p. 168–172 °C; Anal. Calcd for C21H17N5O3S2Br2: C, 41.25, H, 2.80, N, 11.45%; found C, 41.19, H, 2.77, N, 11.43%; IR: 1517 (C⚌CH), 2945 (C⚌CH); 1H NMR: 6.40 (s, 1H, C⚌ CH ), 7.42 (s, 1H, C4H of thiazole), 6.55–7.95 (m, 8H, Ar—H); 13C NMR (δ): 112.2 (C5 of thiazole), 140.8 (C4 of thiazole), 144.6 (C⚌ CH ), 147.8 (C⚌CH), 171.2 (C2 of thiazole), 173.9 (CO cyclic), 119.8, 123.4, 125.4, 126.1, 126.8, 127.8, 128.7, 129.6, 130.4, 131.6, 140.7, 141.9 (12C, Ar); Mass (FAB): 611M+, 583, 531, 427, 424, 401, 396, 240, 214.
2.7.6 Synthesis of N-2-[-{2-(3-bromophenyl)-4-oxo-5-(3-bromobenzylidene)-1-3-thiazolidine}-imino]-ethyl-2-amino-5-nitrothiazole (5f)
Yield: 65%, m.p. 175–177 °C; Anal. Calcd for C21H17N5O3S2Br2: C, 41.25, H, 2.80, N, 11.45%; found C, 41. 20, H, 2.75, N, 11.40%; IR: 1521 (C⚌CH), 2962 (C⚌CH); 1H NMR: 6.24 (s, 1H, C⚌ CH ), 6.58 (s, 1H, C4H of thiazole), 6.58–7.97 (m, 8H, Ar—H); 13C NMR (δ): 112.9 (C5 of thiazole), 139.9 (C4 of thiazole), 144.8 (C⚌ CH ), 148.9 (C⚌CH), 172.3 (C2 of thiazole), 174.7 (CO cyclic), 123.5, 124.7, 126.8, 127.5, 127.9, 128.5, 129.6, 129.8, 130.8, 132.8, 141.7, 142.6 (12C, Ar); Mass (FAB): 611M+.
2.7.7 Synthesis of N-2-[-{2-(2-bromophenyl)-4-oxo-5-(2-bromobenzylidene)-1-3-thiazolidine}-imino]-ethyl-2-amino-5-nitrothiazole (5g)
Yield: 64%, m.p. 176–178 °C; Anal. Calcd for C21H17N5O3S2Br2: C, 41.25, H, 2.80, N, 11.45%; found C, 41.22, H, 2.79, N, 11.42%; IR: 1526 (C⚌CH), 2933 (C⚌CH); 1H NMR: 6.52 (s, 1H, C⚌ CH ), 7.32 (s, 1H, C4H of thiazole), 6.45–8.02 (m, 8H, Ar—H); 13C NMR (δ): 113.4 (C5 of thiazole), 141.4 (C4 of thiazole), 145.1 (C⚌ CH ), 148.5 (C⚌CH), 171.2 (C2 of thiazole), 176.7 (CO cyclic), 119.8, 120.8, 124.9, 125.4, 126.8, 127.6, 128.8, 128.9, 129.9, 130.7, 140.8, 142.6 (12C, Ar); Mass (FAB): 611M+.
2.7.8 Synthesis of N-2-[-{2-(4-nitrophenyl)-4-oxo-5-(4-nitrobenzylidene)-1-3-thiazolidine}-imino]-ethyl-2-amino-5-nitrothiazole (5h)
Yield: 62%, m.p. 171–174 °C; Anal. Calcd for C21H17N7O7S2: C, 46.40, H, 3.15, N, 18.03%; found C, 46.33, H, 3.11, N, 17.93%; IR: 1530 (C⚌CH), 2991 (C⚌CH); 1H NMR: 6.41 (s, 1H, C⚌ CH ), 7.38 (s, 1H, C4H of thiazole), 6.85–8.22 (m, 8H, Ar—H); 13C NMR (δ): 112.2 (C5 of thiazole), 139.4 (C4 of thiazole), 143.6 (C⚌ CH ), 146.5 (C⚌CH), 174.7 (CO cyclic), 170.2 (C2 of thiazole), 126.4, 127.6, 128.8, 128.6, 129.5, 138.8 (12C, Ar); Mass (FAB): 544M+, 540, 470, 444, 357, 327.
2.7.9 Synthesis of N-2-[-{2-(3-nitrophenyl)-4-oxo-5-(3-nitrobenzylidene)-1-3-thiazolidine}-imino]-ethyl-2-amino-5-nitrothiazole (5i)
Yield: 64%, m.p. 176–179 °C; Anal. Calcd for C21H17N7O7S2: C, 46.40, H, 3.15, N, 18.03%; found C, 46.37, H, 3.13, N, 17.98%; IR: 1522 (C⚌CH), 2946 (C⚌CH); 1H NMR: 6.48 (s, 1H, C⚌ CH ), 7.44 (s, 1H, C4H of thiazole), 6.90–8.28 (m, 8H, Ar—H); 13C NMR (δ): 110.2 (C5 of thiazole), 138.4 (C4 of thiazole), 141.8 (C⚌ CH ), 144.9 (C⚌CH), 175.7 (CO cyclic), 169.8 (C2 of thiazole), 118.7, 120.7, 124.9, 125.6, 126.7, 127.5, 128.6, 129.6, 130.4, 132.8, 146.8, 148.6 (12C, Ar); Mass (FAB): 544M+.
2.7.10 Synthesis of N-2-[-{2-(2-nitrophenyl)-4-oxo-5-(2-nitrobenzylidene)-1-3-thiazolidine}-imino]-ethyl-2-amino-5-nitrothiazole (5j)
Yield: 60%, m.p. 177–180 °C; Anal. Calcd for C21H17N7O7S2: C, 46.40, H, 3.15, N, 18.03%; found C, 46.35, H, 3.08, N, 18.00%; IR: 1532 (C⚌CH), 2948 (C⚌CH); 1H NMR: 6.32 (s, 1H, C⚌ CH ), 7.44 (s, 1H, C4H of thiazole), 6.82–8.20 (m, 8H, Ar—H); 13C NMR (δ): 111.2 (C5 of thiazole), 140.4 (C4 of thiazole), 143.7 (C⚌ CH ), 146.6 (C⚌CH), 168.8 (C2 of thiazole), 175.7 (CO cyclic), 116.8, 121.6, 123.8, 125.7, 126.8, 127.6, 128.8, 129.6, 130.6 132.7, 145.6, 146.8 (12C, Ar); Mass (FAB): 544M+.
2.7.11 Synthesis of N-2-[-{2-(4-methoxyphenyl)-4-oxo-5-(4-methoxybenzylidene)-1-3-thiazolidine}-imino]-ethyl-2-amino-5-nitrothiazole (5k)
Yield: 66%, m.p. 155–158 °C; Anal. Calcd for C23H23N5O5S2: C, 53.78, H, 4.51, N, 13.63%; found C, 53.72, H, 4.45, N, 13.56%; IR: 1518 (C⚌CH), 2941 (C⚌CH), 2978 (OCH3); 1H NMR: 3.63 (s, 3H, OCH3), 6.34 (s, 1H, C⚌ CH ), 7.37 (s, 1H, C4H of thiazole), 6.45–7.77 (m, 8H, Ar—H); 13C NMR (δ): 63.5 (OCH3), 108.7 (C5 of thiazole), 138.8 (C4 of thiazole), 144.8 (C⚌ CH ), 148.5 (C⚌CH), 170.5 (C2 of thiazole), 171.7 (CO cyclic), 114.7, 115.7, 120.8, 121.9, 124.6, 125.7, 127.8, 128.8, 128.9, 129.6, 155.6, 156.9 (12C, Ar); Mass (FAB): 514M+, 499, 486, 471, 443.
2.7.12 Synthesis of N-2-[-{2-(4-methylphenyl)-4-oxo-5-(4-methylbenzylidene)-1-3-thiazolidine}-imino]-ethyl-2-amino-5-nitrothiazole (5l)
Yield: 61%, m.p. 152–154 °C; Anal. Calcd for C23H23N5O3S2: C, 57.36, H, 4.81, N, 14.54%; found C, 57.30, H, 4.78, N, 14.50%; IR: 1512 (C⚌CH), 2938 (C⚌CH), 2970 (CH3); 1H NMR: 2.80 (s, 3H, CH3), 6.35 (s, 1H, C⚌ CH ), 7.38 (s, 1H, C4H of thiazole), 6.30–7.90 (m, 8H, Ar—H); 13C NMR (δ): 26.9 (CH3), 107.2 (C5 of thiazole), 136.4 (C4 of thiazole), 141.1 (C⚌ CH ), 146.9 (C⚌CH), 170.3 (CO cyclic), 169.7 (C2 of thiazole), 123.7, 124.5, 125.6, 126.8, 126.8, 127.7, 127.9, 128.6, 129.7, 130.8, 138.6, 139.8 (12C, Ar); Mass (FAB): 482M+, 467, 454, 439, 363, 337.
2.7.13 Synthesis of N-2-[-{2-(4-hydroxyphenyl)-4-oxo-5-(4-hydroxybenzylidene)-1-3-thiazolidine}-imino]-ethyl-2-amino-5-nitrothiazole (5m)
Yield: 62%, m.p. 150–153 °C; Anal. Calcd for C21H19N5O5S2: C, 51.94, H, 3.94, N, 14.42%; found C, 51.80, H, 3.82, N, 14.39%; IR: 1501 (C⚌CH), 2951 (C⚌CH), 3478 (OH); 1H NMR: 4.94 (s, 1H, OH), 6.46 (s, 1H, C⚌ CH ), 7.39 (s, 1H, C4H of thiazole), 6.48–7.58 (m, 8H, Ar—H); 13C NMR (δ): 113.5 (C5 of thiazole), 143.3 (C4 of thiazole), 146.1 (C⚌ CH ), 148.5 (C⚌CH), 171.2 (C2 of thiazole), 173.7 (CO cyclic), 120.9, 124.8, 125.7, 126.6, 127.8, 128.8, 128.9, 129.8, 131.3, 137.5, 138.6, 152.8 (12C, Ar); Mass (FAB): 486M+, 458, 469, 384, 368, 308.
3 Results and discussion
The reaction of 1-bromo-2-chloro-ethane with 2-amino-5-nitrothiazole was carried out in methanol to afford a product compound 1 The spectroscopic analyses of compound 1 showed absorption peaks for N—CH and C—Cl at 1382 and 740 cm−1 in the IR spectrum. In the IR spectrum confirms the formation of compound 1. This fact was also supported by the disappearance of NH absorption of the 2-amino-5-nitrothiazole. The compound 1 on the reaction with hydrazine hydrate with continuous stirring at room temperature yielded compound 2. In the spectroscopic analyses of compound 2 we found two absorption peaks in IR spectrum for NH and NH2 at 3370 and 3480 cm−1 respectively while absorption of C—Cl has disappeared. This is clearly indicated that compound 1 gives the substitution reaction with hydrazine hydrate. This fact was also supported by 1H and 13C NMR spectra because two signals appeared in the 1H NMR spectrum for NH and NH2 at δ 7.70 and δ 5.55 ppm respectively. All the facts together were strong evidence for the synthesis of compound 2. The compound 2 gave the condensation reaction with substituted benzaldehydes resulting in the production of Schiff bases N⚌CH, compound 3(a–m) which was confirmed by IR, 1H NMR and 13C NMR spectra of compound 3(a–m). In the IR spectra an absorption was found in the range of 1549–1609 cm−1 while a strong signal appeared in the range of δ 7.82–8.17 and δ 141.6–156.6 ppm in the 1H NMR and 13C NMR spectra for N⚌CH of compound 3(a–m) respectively. The facts have also supported by the disappearance of the signal of NH2 in the 1H NMR spectra. The compound 3(a–m) on reaction with equimolar amount of thioglycolic acid in the presence of ZnCl2 (act as a catalyst) in the trace amount gives the cycloaddition reaction and produced a five membered thiazolidinone ring, compound 4(a–m). The compound 4(a–m) showed a characteristic absorption for the cyclic carbonyl group in the range of 1738–1749 cm−1 in the IR spectra. The 1H NMR spectra aroused our attention and clearly indicate the presence of the two active methylene protons in the thiazolidine ring in the range of δ 3.10–3.46 ppm. The 13C NMR spectra of compound 4(a–m) also supported the fact that cyclic carbonyl group present and a signal appeared in the range of δ 168.7–177.9 ppm. All these facts were also supported by the two evidences that are (a) disappearance of N⚌CH proton and (b) appearance of N—CH proton in the range of δ 4.74–4.98 ppm in the 1H NMR spectra of compound 4(a–m). The compound 4(a–m) underwent the Knoevenagel condensation reaction with substituted benzaldehydes in the presence of alkali metal alkoxide (C2H5ONa) to afford the compound 5(a–m). In the 1H NMR spectra of the compound 5(a–m), we found the disappearance of two methylene protons of compound 5(a–m) and an appearance of a new signal for C⚌
CH
in the range of δ 6.24–6.52 ppm in the 1H NMR and two new signals for C⚌
CH
and C⚌CH appeared in the range of δ 141.1–146.1 and δ 144.9–148.9 ppm in the 13C NMR spectra of the compound 5(a–m). These all above facts clearly confirmed the synthesis of all final products. All above compounds 1, 2, 3(a–m), 4(a–m) and 5(a–m) were also synthesized by microwave method. Characterization data were given in Table 1. All these above facts clearly confirmed the synthesis of all final products. Antimicrobial and antitubercular data (as shown in Tables 2 and 3) revealed that all the synthesized compound 5(a–m) have a structure activity relationship (SAR) because activity of compounds varies with substitution. Nitro group containing compounds (5h, 5i and 5j) showed higher activity than chloro (5c, 5d), or bromo group containing compounds (5e, 5f). Chloro and bromo derivatives also have higher activity than other rested compounds. On the basis of SAR, it was concluded that the activity of compounds depends on the electron withdrawing nature of the substituted groups. The sequence of the activity is following
Isoniazid and rifampicin were taken as standards, showed 100% activity at 25 and 50 ppm concentrations.
Compound
B. subtilis
E. coli
S. aureus
Compound
A. niger
A. flavus
C. albicans
50 ppm
100 ppm
50 ppm
100 ppm
50 ppm
100 ppm
50 ppm
100 ppm
50 ppm
100 ppm
50 ppm
100 ppm
5a
17
21
17
22
15
23
5a
09
15
17
20
17
20
5b
23
29
20
30
22
28
5b
12
22
15
20
14
24
5c
24
34
22
32
24
30
5c
16
30
12
24
14
30
5d
25
33
20
32
23
31
5d
18
29
10
34
13
31
5e
22
30
22
31
25
33
5e
15
28
12
28
15
31
5f
21
30
21
32
24
30
5f
16
29
11
27
14
30
5g
20
28
20
29
20
27
5g
14
28
10
31
10
28
5h
22
36
19
33
22
34
5h
12
31
09
32
12
35
5i
20
37
20
32
22
33
5i
12
29
10
31
12
33
5j
24
32
21
34
20
35
5j
13
30
11
34
10
32
5k
18
25
19
24
18
24
5k
11
19
10
24
11
23
5l
14
18
14
20
16
22
5l
10
16
10
20
10
20
5m
12
27
23
27
17
28
5m
14
24
13
25
12
27
Streptomycin
28
37
26
34
27
35
Griseofulvin
22
32
20
35
24
36
Compound
% Activity
Compound
% Activity
Compound
% Activity
Compound
% Activity
25 ppm
50 ppm
25 ppm
50 ppm
25 ppm
50 ppm
25 ppm
50 ppm
5a
32
59
5e
50
78
5i
57
83
5m
54
76
5b
52
82
5f
60
79
5j
58
81
–
–
–
5c
53
80
5g
59
76
5k
58
60
–
–
–
5d
62
80
5h
62
82
5l
42
55
–
–
–
Standards
100
100
Standards
100
100
Standards
100
100
Standards
100
100
4 Biological study
Series of newly synthesized compounds were highly active against selected microorganisms. The minimal inhibition values were determined using the filter paper disc diffusion method (Asati et al., 2005) and the concentrations have been used in ppm. All the final synthesized compounds 5(a–m) have dissolved in methanol and screened in vitro for their antibacterial activity against Bacillus subtilis, Escherichia coli and Staphylococcus aureus and antifungal activity against Aspergillus niger, Aspergillus flavus and Candida albicans. Standards for antibacterial and antifungal activity streptomycin and griseofulvin were used respectively. Standards also screened under the similar conditions for comparison. The antitubercular activity screened against the M. tuberculosis. For the antitubercular activity isoniazid and rifampicin were used as standard and also screened under the similar conditions.
4.1 Antibacterial activity
The above synthesized compounds were screened against some selected bacteria and examined for the inhibition of growth of the organism. The concentrations of the compounds were given in ppm. The diameter of the inhibition zones in (mm) were given in Table 2.
4.2 Antifungal activity
The above synthesized compounds were screened against selected fungi and their minimal inhibition zones in (mm) were presented in Table 2 and concentrations of the compounds were given in ppm.
4.3 Antitubercular activity
The above synthesized compounds were screened against M. tuberculosis (H37Rv strain) using L.J. medium (conventional) method at 25 and 50 ppm concentrations. The results were showing in Table 3. The standard antitubercular drugs isoniazid and rifampicin were taken as standards, showed 100% activity at both the above concentrations.
5 Conclusion
Compound 1, 2, 3(a–m), 4(a–m) and 5(a–m) were synthesized by conventional and microwave methods, reaction time and yields of the synthesized compound displayed that the microwave method is more efficient than the conventional method. Compound 5(a–m) were screened for their antibacterial, antifungal and antitubercular activity against selected microorganisms. The investigation of antimicrobial data revealed that the compounds (5c), (5d), (5e), (5f), (5h), (5i) and (5j) displayed highly active in the series, compounds (5b), (5g) and (5m) showed moderate activity and rest compounds showed less activity against all the strains compared with standard drugs.
Acknowledgements
The authors are thankful to SAIF, Central Drugs Research Institute, Lucknow (India) for providing spectral and analytical data of the compounds. We are thankful to Head, Department of Biotechnology, Dr. H.S. Gour, University, Sagar (India) for antimicrobial (antibacterial and antifungal) and Microcare laboratory and Tuberculosis Research Center, Surat, Gujarat (India) for antituberculosis activity. We are also thankful to Head, Department of Chemistry, Dr. H.S. Gour, University, Sagar (India) for giving the facilities to carryout the work.
References
- Chem. – Indian J.. 2005;1(10):667-672.
- Eur. J. Med. Chem.. 2010;45:651-660.
- Bioorg. Med. Chem. Lett.. 2007;17:4213-4217.
- Eur. J. Med. Chem.. 2009;44:2184-2189.
- Eur. J. Med. Chem.. 2010;45:1338-1345.
- J. Indian Chem. Soc.. 2006;83:1-6.
- J. Sci. Ind. Res.. 2001;60:331-335.
- Eur. J. Med. Chem.. 2009;44:4434-4440.
- Bioorg. Med. Chem.. 2009;17:5933-5949.
- Eur. J. Med. Chem.. 2009;44:3272-3279.
- Bioorg. Med. Chem.11 2003:2175-2182.
- J. Pestic. Sci.. 2006;31(3):305-310.
- Bioorg. Med. Chem.. 2004;12:4633-4643.
- Eur. J. Med. Chem.. 2007;42:807-816.
- Int. J. Agri. Bio.. 2007;1:87-93.
- Eur. J. Med. Chem.. 2004;39:433-447.